๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Granulocyte and erythropoietic stimulating proteins after high-dose chemotherapy for myeloma

โœ Scribed by Littlewood, T J; Collins, G P


Book ID
110015470
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
162 KB
Volume
40
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


High-dose cytarabine-containing chemothe
โœ Chen, Shu-Huey; Liang, Der-Cherng; Liu, Hsi-Che ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 27 KB ๐Ÿ‘ 2 views

We sought to determine the role of granulocyte colony-stimulating factor (G-CSF) as an adjunct therapy in high-dose cytarabine-containing chemotherapy (HD C/T) for children with acute leukemia. Seventeen patients, aged 9 months to 18 years old, 8 ALL and 9 AML, were treated with cytarabine (Ara-C) 1

Whole blood harvested after granulocyte-
โœ Vinod Raina; Atul Sharma; Rajive Kumar; Manorama Bhargava ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 446 KB

## BACKGROUND. High-dose melphalan (HDM) is now a standard treatment for multiple myeloma (MM). Stem cell transplants are fast evolving as an alternative to bone marrow transplants because they are less traumatic and easier to perform. A study was undertaken to test if whole blood harvested after